# Cumberland Pharmaceuticals Inc: Form 8-K, filed Jun 25, 2026

- Company: [Cumberland Pharmaceuticals Inc](/companies/cpix.md) (CIK 1087294)
- Form: 8-K
- Filed: 2026-06-25
- Accepted by EDGAR: Jun 25, 2026, 17:00 ET
- Period: 2026-06-24
- Accession: 0001087294-26-000053
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000053/cpix-20260624.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1087294/000108729426000053/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1087294/000108729426000053/cpix-20260624.htm

Filed Jun 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001087294-26-000053. Last ingested by Listed: Nov 14, 2026, 23:39 ET. No prices; not investment advice.
